Aurobindo Pharma’s arm -- Aurobindo Pharma USA Inc is voluntarily recalling Mirtazapine tablets, used for the treatment of major depressive disorder, in the US market. The product is being recalled due to a label error on declared strength.
Mirtazapine tablets are indicated for the treatment of major depressive disorder and are packaged in 500 count bottle.
Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.
